# Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

Study · id `cardio:ct-nct01891058` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01891058](<https://clinicaltrials.gov/study/NCT01891058>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01891058

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 396 participants.

## Technical summary

Registry record NCT01891058. Randomized; single masking; primary purpose treatment. Start 2013-07-18 (actual); primary completion 2018-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 396 participants (enrolled count; ClinicalTrials.gov record NCT01891058, source copy `cardio:ctgov-nct01891058-2019-07-22`, retrieved 2026-10-26)
- Started: 2013-07-18 (actual) (ClinicalTrials.gov record NCT01891058, source copy `cardio:ctgov-nct01891058-2019-07-22`, retrieved 2026-10-26)
- Primary completion: 2018-10 (actual) (ClinicalTrials.gov record NCT01891058, source copy `cardio:ctgov-nct01891058-2019-07-22`, retrieved 2026-10-26)
- Completion: 2018-10-31 (actual) (ClinicalTrials.gov record NCT01891058, source copy `cardio:ctgov-nct01891058-2019-07-22`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01891058, source copy `cardio:ctgov-nct01891058-2019-07-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01891058-2019-07-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED
- Acronym: RAFF-2
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Intervention (Device): drug-shock vs shock only
- Lead sponsor: Ottawa Hospital Research Institute
- Lead sponsor class: OTHER
- Collaborator: The Ottawa Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry lists this organization as the lead sponsor: Ottawa Hospital Research Institute (`cardio:org-ottawa-hospital-research-institute`)
- Registry lists this organization as a collaborator: The Ottawa Hospital (`cardio:org-the-ottawa-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial (`cardio:pubmed-32007169`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4e7afd0bf13e543b31ac4385e8c878a7ca4bcf9d4d6c793ee33b303afb09d166
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
